These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10753057)

  • 1. Influence of human anti-lipopolysaccharide immunoglobulins on tissue distribution and clearance of lipopolysaccharide in rats.
    Nys M; Damas J; Damas P; Laub R; Lamy M
    Med Microbiol Immunol; 1999 Nov; 188(2):65-71. PubMed ID: 10753057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the protective effects of hyperimmune immunoglobulins G and M against endotoxin in mice and rats.
    Nys M; Damas J; Damas P; Laub R; Cloes JM; Lamy M
    Med Microbiol Immunol; 1999 Nov; 188(2):55-64. PubMed ID: 10753056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of specific antibodies, hormones, and lipoproteins on bacterial lipopolysaccharides injected into the rat.
    Munford RS; Dietschy JM
    J Infect Dis; 1985 Jul; 152(1):177-84. PubMed ID: 4040145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey.
    Munford RS; Andersen JM; Dietschy JM
    J Clin Invest; 1981 Dec; 68(6):1503-13. PubMed ID: 7033286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis.
    Bhattacharjee AK; Opal SM; Palardy JE; Drabick JJ; Collins H; Taylor R; Cotton A; Cross AS
    J Infect Dis; 1994 Sep; 170(3):622-9. PubMed ID: 8077720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective properties of a human IgG preparation rich in antibodies to a wide spectrum of lipopolysaccharides.
    Fomsgaard A; Galanos C
    APMIS; 1989 Dec; 97(12):1114-20. PubMed ID: 2611025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice.
    Gallay P; Heumann D; Le Roy D; Barras C; Glauser MP
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7922-6. PubMed ID: 7520172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical application of lipopolysaccharide into gingival sulcus promotes periodontal destruction in rats immunized with lipopolysaccharide.
    Yoshinaga Y; Ukai T; Kaneko T; Nakatsu S; Shiraishi C; Kuramoto A; Oshino K; Ichimura I; Hara Y
    J Periodontal Res; 2012 Oct; 47(5):674-80. PubMed ID: 22582894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned mice.
    Fomsgaard A; Holder IA
    APMIS; 1993 Mar; 101(3):229-34. PubMed ID: 8507460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
    Siber GR; Kania SA; Warren HS
    J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal concentration of human IgM and IgG antibodies necessary to protect mice from challenges with live O6 Escherichia coli.
    Massironi SM; Arslanian C; Carneiro-Sampaio MM; Pontes GN
    FEMS Immunol Med Microbiol; 2011 Nov; 63(2):193-201. PubMed ID: 22077222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection.
    Schiff DE; Wass CA; Cryz SJ; Cross AS; Kim KS
    Infect Immun; 1993 Mar; 61(3):975-80. PubMed ID: 7679376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of IgG subclasses on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lewis rats.
    Arquilla ER; Stenger D; McDougall B; Ulich TR
    Diabetes; 1987 Oct; 36(10):1144-51. PubMed ID: 3308585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular distribution of endotoxin after injection of chemically purified lipopolysaccharide differs from that after injection of live bacteria.
    Ge Y; Ezzell RM; Tompkins RG; Warren HS
    J Infect Dis; 1994 Jan; 169(1):95-104. PubMed ID: 8277203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
    Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
    Cancer Res; 1997 May; 57(10):1955-61. PubMed ID: 9157991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.
    Kerjaschki D; Miettinen A; Farquhar MG
    J Exp Med; 1987 Jul; 166(1):109-28. PubMed ID: 2885390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary study on treatment of septic shock patients with antilipopolysaccharide IgG from blood donors.
    Fomsgaard A; Baek L; Fomsgaard JS; Engquist A
    Scand J Infect Dis; 1989; 21(6):697-708. PubMed ID: 2617211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different serotypes of endotoxin (lipopolysaccharide) cause different increases in albumin extravasation in rats.
    Nedrebø T; Reed RK
    Shock; 2002 Aug; 18(2):138-41. PubMed ID: 12166776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.